Predict your next investment

HEALTHCARE | Drug Development
altravax.com

See what CB Insights has to offer

Total Raised

$4.65M

Investors Count

1

Altravax Funding, Altravax Valuation & Altravax Revenue

2 Fundings

Altravax's latest funding round was a Grant - II for $3.45M on December 3, 2012.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/3/2012

Grant - II

$3.45M

1

10/14/2010

Grant

$99M

0

Date

12/3/2012

10/14/2010

Round

Grant - II

Grant

Amount

$3.45M

$99M

Investors

Valuation

Revenue

Sources

1

0

Altravax Investors

1 Investors

Altravax has 1 investors. National Institute of Allergy and Infectious Diseases invested in Altravax's Grant - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/14/2010

12/3/2012

2
Grant, Grant - II (2012)

Government

Maryland

First funding

10/14/2010

Last Funding

12/3/2012

Investor

Rounds

2
Grant, Grant - II (2012)

Board Seats

Type

Government

Location

Maryland

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.